The article reviews strategies for firms with or without existing in-house capacities and the pros and cons for outsourcing bio/pharmaceutical development and manufacturing.
Oskar Gold
Advertisement
Oskar Gold is Vice President, Key Account Management & Corporate Marketing, at Vetter.
Articles by Oskar Gold
Advertisement
Latest Updated Articles
Insourcing vs Outsourcing: Choosing the Right StrategyPublished: May 15th 2017 | Updated:
Advertisement
Advertisement
